EdgeMarket › What Aigh Capital Management Llc reported owning

What Aigh Capital Management Llc reported owning

As filed on Form 13F for the quarter ending 2026-03-31, up to 45 days after that date. Long-only US-listed equity — shorts, bonds, cash and non-US listings are not on the form, so this is one leg of the book, not the book.

Reported value

733.2M

Positions

43

Quarter

2026-03-31

Shown below

40
largest by value
holdingvalue% of booksharesprice1y
SNDK
Sandisk Corp
127.1M17.3%200.0K1,596.08+3494.8%
TYGO
TIGO ENERGY, INC.
27.4M3.7%7.3M1.09-15.5%
SIMO
Silicon Motion Technology CORP
22.5M3.1%200.0K258.36+248.5%
ZBRA
ZEBRA TECHNOLOGIES CORP
20.9M2.9%100.0K368.51+20.9%
LASR
NLIGHT, INC.
19.4M2.6%340.0K47.39+82.6%
VNDA
Vanda Pharmaceuticals Inc.
19.0M2.6%2.8M5.28+14.8%
PSNL
Personalis, Inc.
18.5M2.5%2.9M18.38+296.1%
GNRC
GENERAC HOLDINGS INC.
17.6M2.4%90.0K205.98+8.6%
KYTX
Kyverna Therapeutics, Inc.
17.3M2.4%2.0M8.42+145.5%
CSTL
CASTLE BIOSCIENCES INC
14.5M2.0%590.6K34.20+72.9%
APPS
Digital Turbine, Inc.
14.1M1.9%4.9M10.87+179.4%
RRX
REGAL REXNORD CORP
14.0M1.9%75.0K166.15+14.7%
ABEO
ABEONA THERAPEUTICS INC.
13.9M1.9%3.1M6.09-13.0%
LRMR
Larimar Therapeutics, Inc.
13.5M1.8%3.0M4.18+10.9%
FENC
FENNEC PHARMACEUTICALS INC.
12.2M1.7%2.0M11.29+39.7%
unmapped CUSIP 29664W10512.1M1.6%4.4M
ZVRA
ZEVRA THERAPEUTICS, INC.
11.2M1.5%1.2M11.87+27.9%
BDSX
BIODESIX INC
11.0M1.5%758.3K26.63+224.7%
IDN
Intellicheck, Inc.
10.6M1.4%1.5M2.95-43.5%
VSTM
Verastem, Inc.
10.6M1.4%2.0M6.89-17.2%
TARA
Protara Therapeutics, Inc.
8.5M1.2%1.6M3.85+27.1%
VUZI
Vuzix Corp
7.6M1.0%3.3M2.94+52.3%
PYPD
PolyPid Ltd.
7.0M1.0%1.6M5.10+45.7%
APYX
Apyx Medical Corp
4.1M0.6%1.1M3.12+53.7%
COYA
Coya Therapeutics, Inc.
3.8M0.5%975.4K4.87-20.8%
ELUT
ELUTIA INC.
3.8M0.5%3.6M0.95-55.1%
RNXT
RenovoRx, Inc.
3.7M0.5%3.7M1.32+51.7%
TLPH
TALPHERA, INC.
3.5M0.5%4.7M1.19+144.4%
WATT
Energous Corp
3.4M0.5%215.0K12.63+69.5%
IPWR
Ideal Power Inc.
3.3M0.5%1.2M4.75-3.3%
NRXS
Neuraxis, INC
3.0M0.4%400.0K6.15+166.2%
BKTI
BK Technologies Corp
2.4M0.3%32.6K78.00+21.1%
LPCN
Lipocine Inc.
1.6M0.2%200.0K2.09-31.2%
INVE
Identiv, Inc.
1.5M0.2%409.2K2.85-21.5%
LPTH
LIGHTPATH TECHNOLOGIES INC
1.0M0.1%100.0K14.42+322.9%
RGNT
REGENTIS BIOMATERIALS LTD.
916.5K0.1%300.0K2.10
APRE
Aprea Therapeutics, Inc.
774.8K0.1%1.0M0.64-59.2%
BFRI
Biofrontera Inc.
740.4K0.1%915.2K1.48+68.2%
QNRX
Quoin Pharmaceuticals, Ltd.
336.6K0.0%51.0K5.57-21.1%
SMTK
SmartKem, Inc.
203.7K0.0%895.4K4.41+563.4%

A position that grew quarter on quarter may simply reflect a higher price: if the stock rose 40% and the manager did nothing, the reported value rose 40%. Reading that as accumulation is reading the price back to yourself. More on that →

The whole archive is one click away.

Screener, filings, insider flow, backtests and the AI — open without an account.

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →